QUEST DIAGNOSTICS INC DGX

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $234.30
Market Cap $26.12B
P/E Ratio 26.78
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑11.8% YoY
$11.04B
3-Yr CAGR: 3.7%
Net Income ↑13.9% YoY
$992.00M
Net Margin: 9.0%
Free Cash Flow ↑49.5% YoY
$1.36B
FCF Yield: 5.20%
EPS (Diluted) ↑13.8% YoY
$8.75
Basic: $8.87
Return on Equity Efficiency
13.8%
ROA: 274.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (DGX)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $7,515.0M $2,899.0M $645.0M $4.51 $1,069.0M $776.0M
FY 2017 $7,709.0M +2.6% $2,990.0M $772.0M +19.7% $5.50 +22.0% $1,175.0M $923.0M +18.9%
FY 2018 $7,531.0M -2.3% $2,605.0M $736.0M -4.7% $5.29 -3.8% $1,200.0M $817.0M -11.5%
FY 2019 $7,726.0M +2.6% $2,689.0M $858.0M +16.6% $6.28 +18.7% $1,243.0M $843.0M +3.2%
FY 2020 $9,437.0M +22.1% $3,633.0M $1,431.0M +66.8% $10.47 +66.7% $2,005.0M $1,587.0M +88.3%
FY 2021 $10,788.0M +14.3% $4,209.0M $1,995.0M +39.4% $15.55 +48.5% $2,233.0M $1,830.0M +15.3%
FY 2022 $9,883.0M -8.4% $3,433.0M $946.0M -52.6% $7.97 -48.7% $1,718.0M $1,314.0M -28.2%
FY 2023 $9,252.0M -6.4% $3,053.0M $854.0M -9.7% $7.49 -6.0% $1,272.0M $864.0M -34.2%
FY 2024 $9,872.0M +6.7% $3,244.0M $871.0M +2.0% $7.69 +2.7% $1,334.0M $909.0M +5.2%
FY 2025 $11,035.0M +11.8% $3,665.0M $992.0M +13.9% $8.75 +13.8% $1,886.0M $1,359.0M +49.5%
$

Valuation

Market Price $234.30
Market Cap $26.12B
Enterprise Value $31.37B
P/E Ratio 26.78
P/B Ratio 3.62
FCF Yield 5.20%
Dividend Yield 3.79%
Shares Outstanding 110,696,400
%

Profitability & Margins

Gross Margin 33.21%
Operating Margin 14.10%
Net Margin 8.99%
Return on Equity (ROE) 13.84%
Return on Assets (ROA) 274.79%
Asset Turnover 30.57x
Revenue 3-Yr CAGR 3.74%
🛡️

Financial Health & Liquidity

Current Ratio 1.07
Cash Ratio 1.24
Debt / Equity 0.791
Debt / Assets 15.709
Cash & Equivalents $420.00M
Total Debt $5.67B
Book Value / Share $64.77
💧

Cash Flow Efficiency

Operating Cash Flow $1.89B
Capital Expenditures (CapEx) $527.00M
Free Cash Flow $1.36B
OCF / Revenue 17.09%
FCF / Revenue 12.32%
FCF 3-Yr CAGR 1.13%
🏷️

Per Share Metrics

EPS (Diluted) $8.75
EPS (Basic) $8.87
Dividends / Share $8.87
Book Value / Share $64.77
EPS YoY Growth 13.78%
🏛️

Balance Sheet (FY 2025)

Total Assets $361.00M
Total Liabilities $338.00M
Stockholders' Equity $7.17B
Current Assets $361.00M
Current Liabilities $338.00M